PROTON LABORATORIES, INC. (PLBI)
Proton Laboratories, Inc., through the acquisition of Regenobody S.A., a Dominican Republic company, is involved in some of the latest technologies associated with stem cell regeneration using the patient's own stem cells.
Recent Price Last
0.01
Market Capitalization $1.08M
Est Float 36M
Outstanding Shares 56M
Quotation OTC.PK
Proton Laboratories, Inc.
1135 Atlantic Avenue
Alameda, CA 94501
Phone: 888-548-3002
Fax: 888-548-3004
http://www.regenobody.com Similar Companies in Sector
· Stem Cell Therapy International, Inc. is a development-stage company. The Company is engaged in the licensing of stem cell technology, the sale of stem cell products, and the referral of patients to affiliated stem cell clinics through its wholly-owned subsidiary Stem Cell Therapy International Corp. OTCBB:SCII Recent Price: $.112
· International Stem Cell Corporation, incorporated is a biotechnology company. The Company is focused on developing therapeutic products and research products. It is in development-stage. The Company’s objective is to create an unlimited source of human cells for use in the treatment of several diseases, including diabetes, liver disease, corneal disease, and retinal disease through cell transplant therapy. OTCBB: ISCO Recent Price: $.83